Clinical trial
Dexmedetomidine vs. Remifentanil for Sedation During AFI
NCT00349245 · The University of Texas Health Science Center, Houston, Other · Completed
Key facts
| NCT number | NCT00349245 |
|---|---|
| Title | Dexmedetomidine vs. Remifentanil for Sedation During AFI |
| Official title | A Randomized, Double-Blind Comparison Of Dexmedetomidine And Remifentanil For Sedation During Awake Fiberoptic Intubations |
| Lead sponsor | The University of Texas Health Science Center, Houston, Other |
| Collaborators | Hospira, now a wholly owned subsidiary of Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Intubation, Endotracheal |
| Intervention type | Drug |
| Interventions | Remifentanil, Dexmedetomidine |
| Enrollment | 30 |
| Start date | Jun 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jul 6, 2006 |
| Last update posted | Mar 23, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: